Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765)

References

Page 1

	Year	Citations
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz, Journal of Clinical Oncology	2006	4.5K
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess, Journal of Clinical Oncology	2008	2.9K
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes Lisa A. Carey, Elizabeth Claire Dees, Lynda Sawyer, Clinical Cancer Research	2007	2.1K
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy Roman Rouzier, Charles M. Perou, W. Fraser Symmans, Clinical Cancer Research	2005	1.9K
Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 Priya Rastogi, Stewart Anderson, Harry D. Bear, Journal of Clinical Oncology	2008	1.8K
REporting recommendations for tumor MARKer prognostic studies (REMARK) Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei, Breast Cancer Research and Treatment Prognostic EvaluationPrognostic BiomarkersMedicinePrognosisPathology	2006	801
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update Manfred Kaufmann, Gabriel N. Hortobágyi, Aron Goldhirsch, Journal of Clinical Oncology Surgical OncologyBreast OncologyMedicinePrimary SystemicCancer Management	2006	718
Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors Valentina Guarneri, Kristine Broglio, Shu‐Wan Kau, Journal of Clinical Oncology	2006	596
Evaluation of HER-2/<i>neu</i> Gene Amplification and Overexpression: Comparison of Frequently Used Assay Methods in a Molecularly Characterized Cohort of Breast Cancer Specimens Michael F. Press, Dennis J. Slamon, Kerry Flom, Journal of Clinical Oncology	2002	388
Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors Marco Colleoni, Giuseppe Viale, David Zahrieh, Clinical Cancer Research	2004	353

Page 1